Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group.
Tripathy, Rabindranath; McHugh, Robert J; Ghose, Arup K; Ott, Gregory R; Angeles, Thelma S; Albom, Mark S; Huang, Zeck; Aimone, Lisa D; Cheng, Mangeng; Dorsey, Bruce D.
Bioorg Med Chem Lett
; 21(24): 7261-4, 2011 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-22061645
Pyrazolone based TGFbetaR1 kinase inhibitors.
Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors.
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.
Evaluation of α-glucosidase inhibiting potentials with docking calculations of synthesized arylidene-pyrazolones.
Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compound.
Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis.
Discovery of fluorescent 3-heteroarylcoumarin derivatives as novel inhibitors of anaplastic lymphoma kinase.
Deletion of the C26 Methyl Substituent from the Bryostatin Analogue Merleâ 23 Has Negligible Impact on Its Biological Profile and Potency.
Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitors.
Design, Synthesis, and Characterization of Some Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis.